AI assistant
Sending…
IDEXX LABORATORIES INC /DE — Director's Dealing 2016
Jun 2, 2016
30016_dirs_2016-06-02_c99b55f7-a8d9-48a8-8c60-bbce0b96566b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2016-06-01
Reporting Person: Williams Michael J PhD (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-06-01 | Common Stock | M | 2598 | — | Acquired | 42696 | Direct |
| 2016-06-01 | Common Stock | F | 805 | $88.18 | Disposed | 41891 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-06-01 | Restricted Stock Unit | $ | M | 2598 | Disposed | Common Stock (2598) | Direct |
Footnotes
F1: Includes 87 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 31, 2016.
F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five equal annual installments, beginning June 1, 2012 and has been adjusted to reflect the the 2-for-1 stock split of Issuer common stock that occurred on June 15, 2015.
F3: Not applicable.
More from IDEXX LABORATORIES INC /DE
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 26